Sustained release nanoparticulate formulations of Rivastigmine tartrate (RT) were prepared,
optimized (using factorial design) and characterized using the biodegradable polymers …

The study aims at formulation and optimization brain targeted nanoparticles (NP) of
Rivastigmine (RT) to improve its therapeutic potential and to verify its safety profile. The NP …

The rivastigmine (RHT) loaded chitosan nanoparticles (CS-RHT NPs) were prepared by
ionic gelation method to improve the bioavailability and enhance the uptake of RHT to the …

The present investigation was aimed at optimization of estradiol loaded PLGA
nanoparticulate formulations resulting in improved oral bioavailability and sustained release …

Alzheimer's disease is a progressive and fatal neurodegenerative disorder manifested by
cognitive and memory deterioration, progressive impairment of activities of daily living, and a …

Background To sustain the effect of rivastigmine, a hydrophilic cholinesterase inhibitor,
nanobased formulations were prepared. The efficacy of the prepared rivastigmine liposomes …

The aim of this work was to develop extended-release poly (d, l-lactide-co-glycolide)(PLGA)
nanoparticles of risperidone and thermal-responsive in situ gel containing risperidone …

Objective: Alzheimer's disease (AD) is a progressive neurodegenerative disorder
manifested by cognitive, memory deterioration and variety of neuropsychiatric symptoms …

The present paper focuses on the development and in vitro/in vivo characterization of
nanoparticles composed of poly-(D, L)-Lactide-co-Glycolide (PLGA) loading Bacoside-A, as …

Currently, there is no treatment strategy which can reverse the process of neuro-
degeneration in progression of Alzheimer's disease (AD). Practically, it is desired to achieve …